Slough Elliott, Pitt-Francis Anna, Belli Antonio, Ahmed Zubair, Di Pietro Valentina, Stevens Andrew R
Neuroscience and Ophthalmology, Department of Inflammation and Ageing, School of Infection, Inflammation and Immunology, University of Birmingham, Edgbaston, Birmingham, UK.
Department of Neurosurgery, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK.
Mol Neurobiol. 2025 May 23. doi: 10.1007/s12035-025-05053-7.
Traumatic brain injury (TBI) is a leading cause of morbidity and mortality worldwide, with few treatment options to mitigate secondary injury. Neutrophil extracellular traps (NETs) may present a potential target for therapy. The systematic review objectives were to characterise NET formation as a feature following TBI; assess the effect of NET modulatory strategies on outcomes; and investigate the relative efficacy of NET modulatory methods. A systematic review was performed, with inclusion criteria of pre-clinical or clinical studies using any model or severity of TBI, and any investigation of the pathophysiological role of NETs and/or modulation of NETs for therapeutic benefit. Following search completion, 849 records were identified with 13 studies eligible for inclusion. All 13 studies characterised NET formation in blood and brain tissue from pre-clinical TBI models, whilst four studies also demonstrated NET formation in serum and brain tissue of TBI patients. Meta-analysis (where ≥ 3 studies reported outcomes) identified that NET modulation was associated with significant improvement of outcomes in preclinical studies, in both modified neurological severity score and latency to falls. No difference in efficacy was identified between NET modulatory methods after sub-group analysis. In addition, the overall risk of bias was judged as high in the included studies. This systematic review and meta-analysis demonstrated that NETs present a promising TBI therapeutic target for future clinical validation. However, the high bias limits this systematic review, and further high-quality studies are required to make definitive conclusions about NET utility as a viable therapeutic strategy in TBI.
创伤性脑损伤(TBI)是全球发病和死亡的主要原因之一,减轻继发性损伤的治疗选择很少。中性粒细胞胞外陷阱(NETs)可能是一个潜在的治疗靶点。本系统评价的目的是将NET形成表征为TBI后的一个特征;评估NET调节策略对结局的影响;并研究NET调节方法的相对疗效。进行了一项系统评价,纳入标准为使用任何TBI模型或严重程度的临床前或临床研究,以及对NETs的病理生理作用和/或NETs调节以获得治疗益处的任何研究。检索完成后,共识别出849条记录,其中13项研究符合纳入标准。所有13项研究均对临床前TBI模型血液和脑组织中的NET形成进行了表征,而4项研究还证实了TBI患者血清和脑组织中存在NET形成。荟萃分析(≥3项研究报告了结局)发现,在临床前研究中,NET调节与结局的显著改善相关,在改良神经功能严重程度评分和跌倒潜伏期方面均有改善。亚组分析后未发现NET调节方法在疗效上存在差异。此外,纳入研究的总体偏倚风险被判定为高。本系统评价和荟萃分析表明,NETs是未来临床验证中一个有前景的TBI治疗靶点。然而,高偏倚限制了本系统评价,需要进一步的高质量研究才能就NET作为TBI可行治疗策略的效用得出明确结论。